OCUGEN, INC. Lease Incentive, Payable, Current
OCUGEN, INC. (OCGN) had Lease Incentive, Payable, Current of $407.00 thousand as of 2016-09-30, per its 10-Q filed 2016-11-10.
Discontinued › Notes › Leases
us-gaap:LeaseIncentivePayableCurrent · last filed 2016-11-10
- 2016-09-30: Lease Incentive, Payable, Current $407.00K.
- 2016-06-30: Lease Incentive, Payable, Current $407.00K.
- 2016-03-31: Lease Incentive, Payable, Current $407.00K.
- 2015-12-31: Lease Incentive, Payable, Current $407.00K.
| Period end | Lease Incentive, Payable, Current |
|---|---|
| 2016-09-30 | $407.00K 10-Q · filed 2016-11-10 |
| 2016-06-30 | $407.00K 10-Q · filed 2016-08-11 |
| 2016-03-31 | $407.00K 10-Q · filed 2016-05-12 |
| 2015-12-31 | $407.00K 10-Q · filed 2016-11-10 |
| 2015-09-30 | $379.00K 10-Q · filed 2015-11-12 |
| 2014-12-31 | $407.00K 10-K · filed 2016-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cabaletta Bio, Inc. (CABA) | United States | $0.365B | -2.81 |
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| Century Therapeutics, Inc. (IPSC) | United States | $0.306B | -4.02 |
| SAB Biotherapeutics, Inc. (SABS) | United States | $0.306B | -25.49 |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| X4 Pharmaceuticals, Inc (XFOR) | United States | $0.297B | -4.99 |
| Inhibikase Therapeutics, Inc. (IKT) | United States | $0.296B | -4.44 |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B |